Literature DB >> 7931435

Optic neuritis: findings on MRI, CSF examination and HLA class II typing in 60 patients and results of a short-term follow-up.

M Söderström1, M Lindqvist, J Hillert, T B Käll, H Link.   

Abstract

Optic neuritis (ON) is a common first manifestation of multiple sclerosis (MS), and examination of patients with ON provides opportunities to study the early clinical stages of MS. This prospective study compares results of brain magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) examinations and HLA-Dw2 phenotyping in 60 consecutive patients with ON. At a median of 17 days after the onset of ON, 69% had oligoclonal IgG bands, and at a median on 79 days after onset, 53% had multiple (> or = 3) white matter lesions on MRI. Subgroup analyses revealed that MRI abnormalities and oligoclonal IgG bands were equally common in patients examined early or late after the onset of ON. Strong correlations were found between the presence of MRI abnormalities and oligoclonal IgG bands. The HLA-Dw2 phenotype was significantly increased in ON patients compared with controls, but also significantly different from a group of MS patients from the same geographical area. A significant relation was found between Dw2 phenotype and oligoclonal IgG bands. During a mean follow-up time of about 2 years, the diagnosis in 17 of the patients changed to clinically definite MS. Initially, 16 of them had oligoclonal IgG bands and 12 had three or more MRI lesions. Both MRI and CSF studies are important diagnostic tools in the workup of ON patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931435     DOI: 10.1007/bf02033357

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  40 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Frequent involvement of the optic radiation in patients with acute isolated optic neuritis.

Authors:  R S Hornabrook; D H Miller; M R Newton; D G MacManus; G H du Boulay; A M Halliday; W I McDonald
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

3.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

Review 4.  Magnetic resonance in multiple sclerosis.

Authors:  D W Paty
Journal:  Curr Opin Neurol Neurosurg       Date:  1993-04

5.  Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

Authors:  K H Lee; S A Hashimoto; J P Hooge; L F Kastrukoff; J J Oger; D K Li; D W Paty
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

6.  T cells recognizing multiple peptides of myelin basic protein are found in blood and enriched in cerebrospinal fluid in optic neuritis and multiple sclerosis.

Authors:  M Söderström; H Link; J B Sun; S Fredrikson; V Kostulas; B Höjeberg; B L Li; T Olsson
Journal:  Scand J Immunol       Date:  1993-03       Impact factor: 3.487

7.  Incidental lesions noted on magnetic resonance imaging of the brain: prevalence and clinical significance in various age groups.

Authors:  I A Awad; R F Spetzler; J A Hodak; C A Awad; F Williams; R Carey
Journal:  Neurosurgery       Date:  1987-02       Impact factor: 4.654

8.  MR imaging of multiple sclerosis: comparison with clinical and CT examinations in 74 patients.

Authors:  J J Sheldon; R Siddharthan; J Tobias; W A Sheremata; K Soila; M Viamonte
Journal:  AJR Am J Roentgenol       Date:  1985-11       Impact factor: 3.959

9.  Clinical and magnetic resonance imaging in optic neuritis.

Authors:  L Jacobs; F E Munschauer; S E Kaba
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

10.  Magnetic resonance imaging and other techniques in the diagnosis of multiple sclerosis.

Authors:  H S Kirshner; S I Tsai; V M Runge; A C Price
Journal:  Arch Neurol       Date:  1985-09
View more
  5 in total

1.  Isolated optic neuritis and its prognosis for multiple sclerosis: a clinical and paraclinical study with evoked potentials. CSF examination and brain MRI.

Authors:  A Ghezzi; V Torri; M Zaffaroni
Journal:  Ital J Neurol Sci       Date:  1996-10

2.  Magnetization transfer histogram analysis of monosymptomatic episodes of neurologic dysfunction: preliminary findings.

Authors:  J S Kaiser; R I Grossman; M Polansky; J K Udupa; Y Miki; S L Galetta
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

Review 3.  [The role of uveitis in demyelinating diseases of the central nervous system].

Authors:  A-M Beyer; B Rosche; U Pleyer; K P Wandinger
Journal:  Nervenarzt       Date:  2007-12       Impact factor: 1.214

Review 4.  Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis.

Authors:  D H Miller; A J Thompson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

5.  The role of magnetic resonance imaging and visual evoked potential in management of optic neuritis.

Authors:  Suha Mikail Al-Eajailat; Mousa Victor Al-Madani Senior
Journal:  Pan Afr Med J       Date:  2014-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.